Skip to content. | Skip to navigation

European Coalition on Homeopathic & Anthroposophic Medicinal Products

Navigation

This page does not seem to exist…

We apologize for the inconvenience, but the page you were trying to access is not at this address. You can use the links below to help you find what you are looking for.

If you are certain you have the correct web address but are encountering an error, please contact the Site Administration.

Thank you.

You might have been looking for…

Our sector
Introduction on the market
New data: homeopathic and anthroposophic medicinal products in Germany
Sales of homeopathic and anthroposophic medicines in Germany grew by 4% between 2014 and 2015.
EU market for homeopathic and anthroposophic medicines grows by over 6% a year
The market for homeopathic and anthroposophic medicinal products in the EU is growing by 6.5% a year. It is now valued at €1.24 billion per year which ...
Market studies
Market studies for EU Member States, European Union and worldwide
Norway welcomes registered homeopathic medicines
Norwegian Medicines Agency outlines simplified requirements for the registration of homeopathic medicinal products, committing to recognise products already ...
Article: Should anthroposophic medicinal products be regulated in Europe?
A new research article in the European Journal of Health Law argues that the 95-year European tradition and good safety profile of anthroposophic products ...
November 2018
New publication - The EU Market for Homeopathic and Anthroposophic Medicinal Products 2018 and new social media campaign: "Release the First report"
16% of Italians use homeopathy once a year
80% of Italians know of homeopathy and 20% of these use it at least once a year, according to new data from Omeoimprese. In-market sales for homeopathic and ...
New surveys confirm support for homeopathy in France and Italy
Two new market surveys confirm solid support for homeopathy amongst patients in France and in Italy.
Council Directive 65/65/EEC on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products
General basis for market authorisation of medicinal products